Sunday, 11 October 2026European Markets

EU Regulations & Policy

2 articles

EU AI Act watermarking mandate drives security research surge as vulnerabilities emerge

EU AI Act watermarking mandate drives security research surge as vulnerabilities emerge

The EU AI Act's watermarking requirements for AI-generated content are fueling increased research into attack methods, following NTT DATA's December 2025 disclosure of vulnerabilities. Security experts predict an arms race between watermarking implementation and circumvention techniques as the regulation takes effect.

ViaNews Editorial Team (Europe)•
The Monolith Problem: Why Europe's AI Governance Must Break With Big Tech's One-Size-Fits-All Model

The Monolith Problem: Why Europe's AI Governance Must Break With Big Tech's One-Size-Fits-All Model

Leading AI researchers are building a compelling case that centralised, large-scale AI development is structurally unsafe and economically exclusionary — and their arguments carry direct implications for European regulators still defining what the AI Act means in practice. At stake is whether the EU will entrench the dominance of a handful of American and Chinese technology giants, or chart a genuinely alternative path.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com